Search Within

Aaron David Goldberg

Formats
  1. Meeting Abstract (71)
  2. Journal Article (32)
  3. Research Letter (6)
  4. Correspondence (4)
  5. Editorial (3)
  6. Review (2)
  7. Book Section (1)
Groups
  1. Adult Leukemia (119)
  2. Center for Hematologic Malignancies (119)
  3. Department of Medicine (119)
  4. Hematologic Malignancies, Division of (119)
  5. Hematology-Oncology Fellows (119)
  6. Weinberg Fellows (119)

More Groups

People
  1. Martin Tallman (49)
  2. Eytan Stein (43)
  3. Christopher Famulare (38)
  4. Andriy Derkach (22)
  5. Ross Levine (21)
  6. Jan Bewersdorf (20)

More People

Years
  1. 2025 (6)
  2. 2024 (20)
  3. 2023 (20)
  4. 2022 (15)
  5. 2021 (15)
  6. 2020 (15)

More Years

Publications
  1. Blood (63)
  2. Leukemia and Lymphoma (8)
  3. American Journal of Hematology (6)
  4. Blood Advances (5)
  5. Journal of Clinical Oncology (5)
  6. British Journal of Haematology (4)

More Publications

Publishers
  1. American Society of Hematology (68)
  2. Taylor & Francis Group (8)
  3. American Society of Clinical Oncology (6)
  4. John Wiley & Sons, Inc. (6)
  5. Elsevier Inc. (4)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (119)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Leukemia stem cell gene expression signatures contribute to acute myeloid leukemia risk stratification
    Editorial

    Knorr, K. L. B.; Goldberg, A. D.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Tolerability and efficacy of crenolanib and cytarabine/anthracycline chemotherapy in older patients (aged 61 to 75) with newly diagnosed FLT3-mutated acute myeloid leukemia (AML)
    Meeting Abstract

    Wang, E. S.; Griffiths, E. A.; Walter, R. B.; Tallman, M. S.; Goldberg, A. D.; Messahel, B.; Stone, R. M.
    Blood (2019)

    Fulltext@MSK | Save
  • Younger patients with newly diagnosed FLT3-mutant AML treated with crenolanib plus chemotherapy achieve adequate free crenolanib levels and durable remissions
    Meeting Abstract

    Goldberg, A. D.; Coombs, C. C.; Wang, E. S.; Walter, R. B.; Karanes, C.; Vigil, C. E.; Messahel, B.; Stone, R. M.; Collins, R. H.
    Blood (2019)

    Fulltext@MSK | Save
  • Combined venetoclax and hypomethylating agent (HMA) therapy induces high response rates in patients with myelodysplastic syndrome including patients previously failing HMA
    Meeting Abstract

    Ball, B. J.; Famulare, C.; Stein, E. M.; Tallman, M. S.; Gill, S. I.; Manning, B. M.; Koprivnikar, J.; McCloskey, J.; Testi, R.; Al Ali, N.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Impact of pre-transplant measurable residual disease on relapse incidence and progression-free survival in older AML/MDS patients following allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Perales, M. A.; Papadopoulos, E. B.; Castro-Malaspina, H.; Gyurkocza, B.; Shaffer, B. C.; Tamari, R.; Tallman, M.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Leukemia cell of origin influences p53 activity and therapeutic sensitivity via an Evi1-dependent mechanism
    Meeting Abstract

    Cai, S. F.; Chu, S.; Goldberg, A. D.; Parvin, S.; Koche, R.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • P2RY8-CRLF2 fusion–positive acute myeloid leukemia with myelodysplasia-related changes: Response to novel therapy
    Journal Article

    Aypar, U.; Taylor, J.; Garcia, J. S.; Momeni-Boroujeni, A.; Gao, Q.; Baik, J.; Londono, D.; Benayed, R.; Sigler, A.; Haddadin, M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Immunotherapy for acute myeloid leukemia: From allogeneic stem cell transplant to novel therapeutics
    Review

    Knorr, D. A.; Goldberg, A. D.; Stein, E. M.; Tallman, M. S.
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save